Overview

A Study To Evaluate The Effect Of Rifampicin Or Ltraconazole On Pharmacokinetics Of Ensartinib In Healthy Volunteers

Status:
NOT_YET_RECRUITING
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of rifampicin or itraconazole on the single dose PK of ensartinib.
Phase:
PHASE1
Details
Lead Sponsor:
Betta Pharmaceuticals Co., Ltd.
Treatments:
ensartinib
Itraconazole
Rifampin